DECREASED PHENYTOIN LEVEL AFTER CARBOPLATIN TREATMENT

被引:20
作者
DOFFERHOFF, ASM
BERENDSEN, HH
VANDERNAALT, J
HAAXMAREICHE, H
SMIT, EF
POSTMUS, PE
机构
关键词
D O I
10.1016/0002-9343(90)90308-Z
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
[No abstract available]
引用
收藏
页码:247 / 248
页数:2
相关论文
共 5 条
[1]
GRAHAMESMITH DG, 1985, OXFORD TXB CLIN PHAR, P158
[2]
CARBOPLATIN AND ETOPOSIDE PHARMACOKINETICS IN PATIENTS WITH TESTICULAR TERATOMA [J].
NEWELL, DR ;
EELES, RA ;
GUMBRELL, LA ;
BOXALL, FE ;
HORWICH, A ;
CALVERT, AH .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 23 (06) :367-372
[3]
POSTMUS PE, IN PRESS SEMIN ONCOL
[4]
ANTIPYRINE METABOLISM IN PATIENTS WITH DISSEMINATED TESTICULAR CANCER AND THE INFLUENCE OF CYTOSTATIC TREATMENT [J].
TEUNISSEN, MWE ;
WILLEMSE, PHB ;
SLEIJFER, DT ;
SLUITER, WJ ;
BREIMER, DD .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1984, 13 (03) :181-185
[5]
VANECHO DA, 1989, SEMIN ONCOL, V16, P1